Candel Therapeutics, Inc. · NASDAQ:CADL
Tyagarajan Seshu sold 7,000 Candel Therapeutics, Inc. shares (Form 4)
Traded Jun 29, 2026 · Filed Jul 1, 2026
On Jun 29, 2026, Tyagarajan Seshu (Chief Technology Officer) sold 7,000 Candel Therapeutics, Inc. shares at US$10.02 for US$70,140 under a trading plan, leaving 83,865 shares. Filed Jul 1, 2026 (Form 4).
- Sold
- 7,000 shares
- Price
- US$10.02
- Value
- US$70,140
- Holding after
- 83,865 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Technology Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | Sale | 7,000 | US$10.02 | 83,865 | Direct |
Source
Related
- Candel Therapeutics, Inc.
- Tyagarajan Seshu
- Candel Therapeutics, Inc. shareholders
- Form 4 · Tyagarajan Seshu · Aug 19, 2026
- Form 4 · Tak Paul Peter · Sep 11, 2026
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Barone Francesca · Jul 1, 2026
- Schedule 13G · Rtw Investments, LP · May 15, 2026
- Schedule 13G/A · BlackRock, Inc. · Apr 27, 2026